TAE Life Sciences News and Activities

TAE Life Sciences is owned by TAE Technologies.

They are in:

• Energy67%
• Biotechnology33%

Acquisition, funding and merger involving TAE Technologies.

• TAE Technologies and Trump Media & Technology Group have announced they will merge  (posted on December 22 2025)..
• TAE Technologies has just announced a $150 Million fundraising (posted on June 20 2025).

View the org chart displaying its 9 main executives

Most searched biographies at TAE Life Sciences

• Robert Hill, Chief Executive Officer
• Michl Binderbauer, Director
• Stuart Peterson, Director

Popular executive movements at TAE Technologies

• Jeff Woodbury has joined the company as President and Chief Operating Officer  (posted on June 18 2026).

Create your alert
to follow the executive moves at TAE Life Sciences.

TAE Technologies has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by TAE Life Sciences

• TAE Life Sciences Signs Biddle Sawyer to Manufacture Boronated TC220 Drug for BNCT Cancer Treatment
• TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)
• TAE Life Sciences Inks $40M Series A Funding
• TAE Life Sciences Announces Partnership with HDX Corporation for Launch of Boron Neutron Capture Therapy in South Korea
• TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma
• TAE Life Sciences Sponsored Study Details Results of Proton Boron Fusion Therapy Biological Effectiveness
• RaySearch and TAE Life Sciences Announce Agreement on RayStation Support for the Alphabeam System for BNCT
• TAE Life Sciences Announces Scientific Advisory Board to Advance Cancer Research in Boron-Neutron Capture Therapy
• TAE Life Sciences Adds Seasoned Chief Operating Officer to Scale New Radiation Treatment Platform
• https://taelifesciences.com/wp-content/uploads/TAE_Life_Sciences_Hill_PressRelease.pdf
• View more press releases Close

Social media about TAE Life Sciences

• TAE Life Sciences on Wikipedia, Google News & Yahoo Finance
• TAE Life Sciences on LinkedIn, X (Twitter) & YouTube